Findings of new study led by Martina Gentzsch, PhD, at the - TopicsExpress



          

Findings of new study led by Martina Gentzsch, PhD, at the University of North Carolina School of Medicine and the UNC Marsico Lung Institute in Chapel Hill, N.C. could help drug developers improve compounds designed to correct CFTR proteins in cystic fibrosis (CF) patients. In lab experiments using tissue samples cultured from cystic fibrosis patients, UNC Dr. Gentzsch and her team of scientists have demonstrated that a new CF drug counteracts the intended beneficial molecular effect of another CF drug. via Cystic Fibrosis News
Posted on: Tue, 29 Jul 2014 13:37:16 +0000

Trending Topics



Recently Viewed Topics




© 2015